✦ LIBER ✦

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer

Book ID: 122086996
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 305 KB
Volume: 10
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(93)90444-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biological and clinical results of a neu

✍ Lissoni, P; Tisi, E; Barni, S; Ardizzoia, A; Rovelli, F; Rescaldani, R; Ballabio 📂 Article 📅 1992 🏛 Nature Publishing Group 🌐 English ⚖ 742 KB

A randomized study of chemotherapy with

A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state

✍ P. Lissoni; F. Paolorossi; A. Ardizzoia; S. Barni; M. Chilelli; M. Mancuso; G. T 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

A randomized study of immunotherapy with

A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 138 KB

227 Paclitaxel, carboplatin and mitomyci

227 Paclitaxel, carboplatin and mitomycin as first-line treatment in patients (PTS) with advanced non-small cell lung cancer (NSCLC)

✍ Zarogoulidis, K.; Papagiannis, A.; Constantinidis, T.C.; Vogiatzis, A.K.; Pella, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Randomized Phase II Study of Vandetanib

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

✍ Heymach, J. V.; Paz-Ares, L.; De Braud, F.; Sebastian, M.; Stewart, D. J.; Eberh 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB

PCN23 A COST MINIMIZATION ANALYSIS OF FI

PCN23 A COST MINIMIZATION ANALYSIS OF FIRST-LINE POLYCHEMOTHERAPY REGIMENS IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER

✍ K Le Lay; L Riou-França; S Avoinet; N Chemali; A Vergnenègre; R Launois 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB